

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of posttranscriptional gene silencing (GO:0060147) | 5.74440922 |
| 2 | regulation of gene silencing by miRNA (GO:0060964) | 5.74440922 |
| 3 | regulation of gene silencing by RNA (GO:0060966) | 5.74440922 |
| 4 | pseudouridine synthesis (GO:0001522) | 4.02967473 |
| 5 | rRNA modification (GO:0000154) | 3.91658493 |
| 6 | rRNA methylation (GO:0031167) | 3.86563879 |
| 7 | transcription from mitochondrial promoter (GO:0006390) | 3.78461674 |
| 8 | mitochondrial RNA metabolic process (GO:0000959) | 3.66620591 |
| 9 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.59755737 |
| 10 | regulation of hippo signaling (GO:0035330) | 3.51625097 |
| 11 | ribosome biogenesis (GO:0042254) | 3.44121965 |
| 12 | ribosome assembly (GO:0042255) | 3.36933789 |
| 13 | pre-miRNA processing (GO:0031054) | 3.35765888 |
| 14 | valine metabolic process (GO:0006573) | 3.30732593 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.30058740 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 3.29486288 |
| 17 | L-phenylalanine catabolic process (GO:0006559) | 3.20799443 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.20799443 |
| 19 | nuclear pore complex assembly (GO:0051292) | 3.20137884 |
| 20 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.17367498 |
| 21 | tryptophan catabolic process (GO:0006569) | 3.16963716 |
| 22 | indole-containing compound catabolic process (GO:0042436) | 3.16963716 |
| 23 | indolalkylamine catabolic process (GO:0046218) | 3.16963716 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 3.14970955 |
| 25 | L-phenylalanine metabolic process (GO:0006558) | 3.14428789 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.14428789 |
| 27 | tryptophan metabolic process (GO:0006568) | 3.13121205 |
| 28 | tRNA methylation (GO:0030488) | 3.09669335 |
| 29 | signal peptide processing (GO:0006465) | 3.09382340 |
| 30 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.03042845 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.98883416 |
| 32 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.97489413 |
| 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.97489413 |
| 34 | homocysteine metabolic process (GO:0050667) | 2.96002703 |
| 35 | ncRNA 3-end processing (GO:0043628) | 2.93859600 |
| 36 | nuclear pore organization (GO:0006999) | 2.89837360 |
| 37 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.88617862 |
| 38 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.88617862 |
| 39 | urea metabolic process (GO:0019627) | 2.88366939 |
| 40 | urea cycle (GO:0000050) | 2.88366939 |
| 41 | cysteine metabolic process (GO:0006534) | 2.87228122 |
| 42 | nodal signaling pathway (GO:0038092) | 2.85060748 |
| 43 | peptidyl-histidine modification (GO:0018202) | 2.84676898 |
| 44 | kynurenine metabolic process (GO:0070189) | 2.83555033 |
| 45 | rRNA processing (GO:0006364) | 2.80619413 |
| 46 | DNA replication initiation (GO:0006270) | 2.80529878 |
| 47 | alpha-linolenic acid metabolic process (GO:0036109) | 2.77565706 |
| 48 | protein complex localization (GO:0031503) | 2.76849660 |
| 49 | rRNA metabolic process (GO:0016072) | 2.74885719 |
| 50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.74213472 |
| 51 | snRNA transcription (GO:0009301) | 2.73816851 |
| 52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.73257630 |
| 53 | serine family amino acid biosynthetic process (GO:0009070) | 2.72720969 |
| 54 | rRNA transcription (GO:0009303) | 2.71036233 |
| 55 | lysine metabolic process (GO:0006553) | 2.69493033 |
| 56 | lysine catabolic process (GO:0006554) | 2.69493033 |
| 57 | positive regulation of chromosome segregation (GO:0051984) | 2.69431818 |
| 58 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.69383614 |
| 59 | glycine metabolic process (GO:0006544) | 2.69259433 |
| 60 | regulation of gene silencing (GO:0060968) | 2.67914532 |
| 61 | high-density lipoprotein particle remodeling (GO:0034375) | 2.67691319 |
| 62 | inner cell mass cell proliferation (GO:0001833) | 2.67405672 |
| 63 | * dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.66543921 |
| 64 | branched-chain amino acid catabolic process (GO:0009083) | 2.66451140 |
| 65 | DNA replication checkpoint (GO:0000076) | 2.65962594 |
| 66 | bile acid and bile salt transport (GO:0015721) | 2.65149349 |
| 67 | histone arginine methylation (GO:0034969) | 2.63850942 |
| 68 | serine family amino acid catabolic process (GO:0009071) | 2.63769983 |
| 69 | nitrogen cycle metabolic process (GO:0071941) | 2.62584524 |
| 70 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.62465710 |
| 71 | COPI coating of Golgi vesicle (GO:0048205) | 2.61581935 |
| 72 | Golgi transport vesicle coating (GO:0048200) | 2.61581935 |
| 73 | intestinal cholesterol absorption (GO:0030299) | 2.60835900 |
| 74 | regulation of translational fidelity (GO:0006450) | 2.60803913 |
| 75 | branched-chain amino acid metabolic process (GO:0009081) | 2.60119291 |
| 76 | ER overload response (GO:0006983) | 2.59979787 |
| 77 | DNA strand elongation (GO:0022616) | 2.59715967 |
| 78 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.59528094 |
| 79 | ncRNA processing (GO:0034470) | 2.59077417 |
| 80 | regulation of triglyceride catabolic process (GO:0010896) | 2.58991410 |
| 81 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.58379040 |
| 82 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.58312856 |
| 83 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.56628097 |
| 84 | * nucleotide-sugar metabolic process (GO:0009225) | 2.56412352 |
| 85 | COPII vesicle coating (GO:0048208) | 2.55927425 |
| 86 | mRNA cleavage (GO:0006379) | 2.55805472 |
| 87 | amino-acid betaine metabolic process (GO:0006577) | 2.55372054 |
| 88 | glyoxylate metabolic process (GO:0046487) | 2.55155890 |
| 89 | protein localization to chromosome, centromeric region (GO:0071459) | 2.55105350 |
| 90 | bile acid biosynthetic process (GO:0006699) | 2.55081215 |
| 91 | maturation of 5.8S rRNA (GO:0000460) | 2.54022840 |
| 92 | glomerular visceral epithelial cell development (GO:0072015) | 2.51379541 |
| 93 | phospholipid efflux (GO:0033700) | 2.50762262 |
| 94 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.50671721 |
| 95 | protein carboxylation (GO:0018214) | 2.50671721 |
| 96 | protein localization to kinetochore (GO:0034501) | 2.49431180 |
| 97 | bile acid metabolic process (GO:0008206) | 2.48177612 |
| 98 | purine nucleobase biosynthetic process (GO:0009113) | 2.47943250 |
| 99 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.47343280 |
| 100 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.47343280 |
| 101 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.47343280 |
| 102 | tRNA modification (GO:0006400) | 2.46909913 |
| 103 | serine family amino acid metabolic process (GO:0009069) | 2.45785664 |
| 104 | lymphocyte apoptotic process (GO:0070227) | 2.45296888 |
| 105 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.44637577 |
| 106 | folic acid metabolic process (GO:0046655) | 2.43931075 |
| 107 | tetrahydrofolate metabolic process (GO:0046653) | 2.43769736 |
| 108 | regulation of cholesterol esterification (GO:0010872) | 2.43531675 |
| 109 | protein-lipid complex remodeling (GO:0034368) | 2.43506783 |
| 110 | macromolecular complex remodeling (GO:0034367) | 2.43506783 |
| 111 | plasma lipoprotein particle remodeling (GO:0034369) | 2.43506783 |
| 112 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.42427086 |
| 113 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.42427086 |
| 114 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.42427086 |
| 115 | plasma lipoprotein particle assembly (GO:0034377) | 2.41929982 |
| 116 | aromatic amino acid family metabolic process (GO:0009072) | 2.41594169 |
| 117 | viral mRNA export from host cell nucleus (GO:0046784) | 2.40707828 |
| 118 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.40050040 |
| 119 | basic amino acid transport (GO:0015802) | 2.39863489 |
| 120 | mitotic nuclear envelope disassembly (GO:0007077) | 2.39774255 |
| 121 | telomere maintenance via telomerase (GO:0007004) | 2.39652969 |
| 122 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.39512660 |
| 123 | intestinal absorption (GO:0050892) | 2.39248789 |
| 124 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.39075338 |
| 125 | mitotic metaphase plate congression (GO:0007080) | 2.38307302 |
| 126 | aldehyde catabolic process (GO:0046185) | 2.38002553 |
| 127 | reverse cholesterol transport (GO:0043691) | 2.37923184 |
| 128 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.37678814 |
| 129 | L-serine metabolic process (GO:0006563) | 2.37535650 |
| 130 | RNA-dependent DNA replication (GO:0006278) | 2.37453038 |
| 131 | regulation of translational termination (GO:0006449) | 2.37193448 |
| 132 | ncRNA metabolic process (GO:0034660) | 2.36922249 |
| 133 | fatty acid beta-oxidation (GO:0006635) | 2.36597388 |
| 134 | cellular glucuronidation (GO:0052695) | 2.36572042 |
| 135 | negative regulation of mRNA processing (GO:0050686) | 2.36196196 |
| 136 | cellular biogenic amine catabolic process (GO:0042402) | 2.36036468 |
| 137 | amine catabolic process (GO:0009310) | 2.36036468 |
| 138 | protein autoprocessing (GO:0016540) | 2.35544106 |
| 139 | T cell apoptotic process (GO:0070231) | 2.34959591 |
| 140 | tRNA processing (GO:0008033) | 2.34779229 |
| 141 | pore complex assembly (GO:0046931) | 2.34689922 |
| 142 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.34677205 |
| 143 | termination of RNA polymerase III transcription (GO:0006386) | 2.34677205 |
| 144 | negative regulation of cholesterol transport (GO:0032375) | 2.34407530 |
| 145 | negative regulation of sterol transport (GO:0032372) | 2.34407530 |
| 146 | anterior/posterior axis specification, embryo (GO:0008595) | 2.34336192 |
| 147 | xenobiotic catabolic process (GO:0042178) | 2.34328670 |
| 148 | peptide catabolic process (GO:0043171) | 2.34110571 |
| 149 | folic acid-containing compound metabolic process (GO:0006760) | 2.32680689 |
| 150 | heterochromatin organization (GO:0070828) | 2.32423836 |
| 151 | DNA geometric change (GO:0032392) | 2.31737349 |
| 152 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.31215592 |
| 153 | DNA duplex unwinding (GO:0032508) | 2.30705160 |
| 154 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.30450743 |
| 155 | proline biosynthetic process (GO:0006561) | 2.30373247 |
| 156 | nucleobase biosynthetic process (GO:0046112) | 2.30274957 |
| 157 | RNA modification (GO:0009451) | 2.30064110 |
| 158 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.30021651 |
| 159 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.30021651 |
| 160 | tRNA metabolic process (GO:0006399) | 2.29071774 |
| 161 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.29007136 |
| 162 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.28868776 |
| 163 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.28868776 |
| 164 | DNA double-strand break processing (GO:0000729) | 2.28101823 |
| 165 | RNA methylation (GO:0001510) | 2.27342947 |
| 166 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.26204939 |
| 167 | tRNA aminoacylation for protein translation (GO:0006418) | 2.25881372 |
| 168 | fatty acid oxidation (GO:0019395) | 2.25590055 |
| 169 | regulation of metalloenzyme activity (GO:0048552) | 2.23587041 |
| 170 | lipoprotein metabolic process (GO:0042157) | 2.23272175 |
| 171 | alpha-amino acid catabolic process (GO:1901606) | 2.22359913 |
| 172 | glucuronate metabolic process (GO:0019585) | 2.22111438 |
| 173 | uronic acid metabolic process (GO:0006063) | 2.22111438 |
| 174 | DNA deamination (GO:0045006) | 2.22036765 |
| 175 | lipid oxidation (GO:0034440) | 2.20663074 |
| 176 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.19245373 |
| 177 | phospholipid homeostasis (GO:0055091) | 2.18830396 |
| 178 | response to interferon-beta (GO:0035456) | 2.18721505 |
| 179 | sulfur amino acid metabolic process (GO:0000096) | 2.18336307 |
| 180 | cholesterol efflux (GO:0033344) | 2.17936895 |
| 181 | indolalkylamine metabolic process (GO:0006586) | 2.17462568 |
| 182 | cellular response to interferon-beta (GO:0035458) | 2.17362449 |
| 183 | positive regulation of interferon-alpha production (GO:0032727) | 2.15882045 |
| 184 | plasma lipoprotein particle organization (GO:0071827) | 2.15627314 |
| 185 | ribosomal small subunit assembly (GO:0000028) | 2.15264810 |
| 186 | complement activation, alternative pathway (GO:0006957) | 2.15133532 |
| 187 | protein-lipid complex assembly (GO:0065005) | 2.14142050 |
| 188 | regulation of protein activation cascade (GO:2000257) | 2.14141373 |
| 189 | cellular amino acid catabolic process (GO:0009063) | 2.13729398 |
| 190 | * nucleotide-sugar biosynthetic process (GO:0009226) | 2.13642010 |
| 191 | 2-oxoglutarate metabolic process (GO:0006103) | 2.13412717 |
| 192 | plasma lipoprotein particle clearance (GO:0034381) | 2.11898688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.51939401 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.44819100 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.05159816 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.03932881 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.94976334 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.91267524 |
| 7 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.83032027 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.73984947 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.73499704 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.72113403 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.59788496 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.42745675 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.37610725 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.34203573 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.32633264 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29283275 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.21667974 |
| 18 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20222271 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.19528478 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.18057145 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08216546 |
| 22 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.05437852 |
| 23 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.02758573 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02621328 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.94233748 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89917760 |
| 27 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.83560391 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.82330400 |
| 29 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.78320307 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77904886 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75640832 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71597465 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70280799 |
| 34 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.69343581 |
| 35 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.69274673 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66783973 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.65146201 |
| 38 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.63473122 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60232614 |
| 40 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.59447513 |
| 41 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.53723816 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.53223258 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52790091 |
| 44 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52343563 |
| 45 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.52171337 |
| 46 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.49870939 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.49686974 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49639799 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46768012 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.46113765 |
| 51 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.45592884 |
| 52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41987077 |
| 53 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.40800896 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40578899 |
| 55 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40395087 |
| 56 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.39860242 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38859889 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37913790 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36385398 |
| 60 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.35952477 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35532641 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33437141 |
| 63 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.32425846 |
| 64 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31303312 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.30134276 |
| 66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.28562835 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.28444586 |
| 68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.28229563 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27718538 |
| 70 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.27032941 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26197707 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25874502 |
| 73 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25847920 |
| 74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.23974039 |
| 75 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.23506797 |
| 76 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.23160338 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23144956 |
| 78 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23045119 |
| 79 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.21559523 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.20470131 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19569354 |
| 82 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18967644 |
| 83 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.17703510 |
| 84 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17490063 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17392530 |
| 86 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.15994312 |
| 87 | MYB_26560356_Chip-Seq_TH1_Human | 1.14907695 |
| 88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14544228 |
| 89 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13683475 |
| 90 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11637851 |
| 91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11611697 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.10531506 |
| 93 | MYB_26560356_Chip-Seq_TH2_Human | 1.09297733 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09127134 |
| 95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.09024482 |
| 96 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08773730 |
| 97 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06553497 |
| 98 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06553497 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06055180 |
| 100 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05709821 |
| 101 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.05464723 |
| 102 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.05081092 |
| 103 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04764701 |
| 104 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.03815981 |
| 105 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03528043 |
| 106 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03123450 |
| 107 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02860073 |
| 108 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.01716208 |
| 109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01145141 |
| 110 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00537658 |
| 111 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00053926 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99291534 |
| 113 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.99045008 |
| 114 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.98792327 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98641138 |
| 116 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.97456516 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97445852 |
| 118 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.97166979 |
| 119 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96822250 |
| 120 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96374273 |
| 121 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96098265 |
| 122 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.96093782 |
| 123 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.95797058 |
| 124 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94675546 |
| 125 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93811065 |
| 126 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.93622659 |
| 127 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92723031 |
| 128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.92311832 |
| 129 | MAF_26560356_Chip-Seq_TH1_Human | 0.92072076 |
| 130 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91784795 |
| 131 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.91188010 |
| 132 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.90869131 |
| 133 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.90235545 |
| 134 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.90099898 |
| 135 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89606899 |
| 136 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.89258002 |
| 137 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.89251262 |
| 138 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88606372 |
| 139 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.88473821 |
| 140 | MYC_22102868_ChIP-Seq_BL_Human | 0.88250654 |
| 141 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87911479 |
| 142 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.87838040 |
| 143 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87043918 |
| 144 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87043247 |
| 145 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86777901 |
| 146 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.86666416 |
| 147 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86293446 |
| 148 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.86163744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.84393418 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.00769817 |
| 3 | MP0005360_urolithiasis | 3.85209136 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.46709320 |
| 5 | MP0005365_abnormal_bile_salt | 3.42075754 |
| 6 | MP0008057_abnormal_DNA_replication | 3.27229645 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.09656192 |
| 8 | MP0010094_abnormal_chromosome_stability | 2.82249465 |
| 9 | MP0003111_abnormal_nucleus_morphology | 2.77356989 |
| 10 | MP0003941_abnormal_skin_development | 2.65722292 |
| 11 | MP0009840_abnormal_foam_cell | 2.44430483 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.30017783 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.28427191 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.25697656 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.19751093 |
| 16 | MP0003077_abnormal_cell_cycle | 2.04047193 |
| 17 | MP0002166_altered_tumor_susceptibility | 1.98879246 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.96226249 |
| 19 | * MP0003718_maternal_effect | 1.93417961 |
| 20 | MP0001873_stomach_inflammation | 1.88633963 |
| 21 | MP0003252_abnormal_bile_duct | 1.87949960 |
| 22 | MP0009785_altered_susceptibility_to | 1.84202174 |
| 23 | MP0003186_abnormal_redox_activity | 1.80148954 |
| 24 | MP0003436_decreased_susceptibility_to | 1.72015403 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.71599053 |
| 26 | MP0005671_abnormal_response_to | 1.71030203 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.68084614 |
| 28 | MP0004233_abnormal_muscle_weight | 1.64659187 |
| 29 | MP0002796_impaired_skin_barrier | 1.62030162 |
| 30 | MP0006082_CNS_inflammation | 1.60597068 |
| 31 | MP0002006_tumorigenesis | 1.59858680 |
| 32 | MP0005025_abnormal_response_to | 1.59367860 |
| 33 | MP0005332_abnormal_amino_acid | 1.58372532 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.58097398 |
| 35 | MP0001730_embryonic_growth_arrest | 1.57135516 |
| 36 | MP0001661_extended_life_span | 1.54154131 |
| 37 | MP0002132_abnormal_respiratory_system | 1.53742478 |
| 38 | MP0010307_abnormal_tumor_latency | 1.53702454 |
| 39 | MP0000609_abnormal_liver_physiology | 1.53684864 |
| 40 | MP0008932_abnormal_embryonic_tissue | 1.52612697 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.52575851 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.51141216 |
| 43 | MP0005083_abnormal_biliary_tract | 1.50646432 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.46249687 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.44346275 |
| 46 | MP0001764_abnormal_homeostasis | 1.44071284 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.43384807 |
| 48 | MP0002419_abnormal_innate_immunity | 1.42838490 |
| 49 | MP0003724_increased_susceptibility_to | 1.42384527 |
| 50 | MP0005501_abnormal_skin_physiology | 1.41031782 |
| 51 | MP0005257_abnormal_intraocular_pressure | 1.36843462 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.35715246 |
| 53 | MP0000685_abnormal_immune_system | 1.35269871 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.34109318 |
| 55 | MP0008469_abnormal_protein_level | 1.33624048 |
| 56 | MP0009764_decreased_sensitivity_to | 1.30205983 |
| 57 | MP0005380_embryogenesis_phenotype | 1.29940930 |
| 58 | MP0001672_abnormal_embryogenesis/_devel | 1.29940930 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.28984669 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.27408513 |
| 61 | MP0000350_abnormal_cell_proliferation | 1.26667856 |
| 62 | MP0002452_abnormal_antigen_presenting | 1.26430596 |
| 63 | MP0003890_abnormal_embryonic-extraembry | 1.25921331 |
| 64 | MP0001800_abnormal_humoral_immune | 1.25294518 |
| 65 | MP0002089_abnormal_postnatal_growth/wei | 1.24901062 |
| 66 | MP0001853_heart_inflammation | 1.24655004 |
| 67 | MP0001697_abnormal_embryo_size | 1.24367414 |
| 68 | MP0000490_abnormal_crypts_of | 1.23920866 |
| 69 | MP0003984_embryonic_growth_retardation | 1.23372623 |
| 70 | MP0004272_abnormal_basement_membrane | 1.23012628 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.22339218 |
| 72 | MP0009697_abnormal_copulation | 1.20908684 |
| 73 | MP0002723_abnormal_immune_serum | 1.20842250 |
| 74 | MP0005310_abnormal_salivary_gland | 1.20061364 |
| 75 | MP0005000_abnormal_immune_tolerance | 1.19780853 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.19738485 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.19738485 |
| 78 | MP0002088_abnormal_embryonic_growth/wei | 1.18559484 |
| 79 | MP0003195_calcinosis | 1.17948583 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 1.17881375 |
| 81 | MP0002086_abnormal_extraembryonic_tissu | 1.16215570 |
| 82 | MP0003693_abnormal_embryo_hatching | 1.15506392 |
| 83 | MP0001790_abnormal_immune_system | 1.15413586 |
| 84 | MP0005387_immune_system_phenotype | 1.15413586 |
| 85 | MP0003300_gastrointestinal_ulcer | 1.14663107 |
| 86 | MP0001881_abnormal_mammary_gland | 1.14031294 |
| 87 | MP0003763_abnormal_thymus_physiology | 1.11809545 |
| 88 | MP0006054_spinal_hemorrhage | 1.11671985 |
| 89 | MP0002405_respiratory_system_inflammati | 1.11564637 |
| 90 | MP0001819_abnormal_immune_cell | 1.10707136 |
| 91 | MP0005408_hypopigmentation | 1.09113262 |
| 92 | MP0000598_abnormal_liver_morphology | 1.08971566 |
| 93 | MP0002420_abnormal_adaptive_immunity | 1.08453919 |
| 94 | MP0004147_increased_porphyrin_level | 1.08269666 |
| 95 | MP0004019_abnormal_vitamin_homeostasis | 1.07838226 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 1.07574048 |
| 97 | MP0000003_abnormal_adipose_tissue | 1.07520476 |
| 98 | * MP0002080_prenatal_lethality | 1.06442752 |
| 99 | MP0001348_abnormal_lacrimal_gland | 1.06340786 |
| 100 | MP0004947_skin_inflammation | 1.05499768 |
| 101 | MP0003866_abnormal_defecation | 1.05277115 |
| 102 | MP0002118_abnormal_lipid_homeostasis | 1.04618240 |
| 103 | MP0000627_abnormal_mammary_gland | 1.02548224 |
| 104 | MP0003786_premature_aging | 1.01897041 |
| 105 | MP0000538_abnormal_urinary_bladder | 1.01730024 |
| 106 | * MP0005395_other_phenotype | 1.01273872 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 1.01176522 |
| 108 | MP0008877_abnormal_DNA_methylation | 1.00796266 |
| 109 | MP0003566_abnormal_cell_adhesion | 0.99481235 |
| 110 | MP0009763_increased_sensitivity_to | 0.97909163 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.97766080 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.97483723 |
| 113 | MP0003937_abnormal_limbs/digits/tail_de | 0.97017556 |
| 114 | MP0002085_abnormal_embryonic_tissue | 0.96902934 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.96706415 |
| 116 | MP0002009_preneoplasia | 0.95435714 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95331685 |
| 118 | MP0002398_abnormal_bone_marrow | 0.95163448 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.94986663 |
| 120 | MP0000716_abnormal_immune_system | 0.94920950 |
| 121 | MP0004197_abnormal_fetal_growth/weight/ | 0.93008812 |
| 122 | MP0002722_abnormal_immune_system | 0.92755197 |
| 123 | MP0003868_abnormal_feces_composition | 0.92294825 |
| 124 | MP0000313_abnormal_cell_death | 0.91322482 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.91217445 |
| 126 | MP0008007_abnormal_cellular_replicative | 0.91089573 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.91037699 |
| 128 | MP0006036_abnormal_mitochondrial_physio | 0.90573001 |
| 129 | MP0002084_abnormal_developmental_patter | 0.90206485 |
| 130 | MP0001756_abnormal_urination | 0.89235615 |
| 131 | MP0009672_abnormal_birth_weight | 0.88741520 |
| 132 | MP0002429_abnormal_blood_cell | 0.87428493 |
| 133 | MP0000858_altered_metastatic_potential | 0.87005184 |
| 134 | MP0008438_abnormal_cutaneous_collagen | 0.86167919 |
| 135 | MP0001849_ear_inflammation | 0.86044738 |
| 136 | MP0002136_abnormal_kidney_physiology | 0.85633662 |
| 137 | MP0004957_abnormal_blastocyst_morpholog | 0.85484304 |
| 138 | MP0005451_abnormal_body_composition | 0.85331987 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.83269994 |
| 140 | MP0008961_abnormal_basal_metabolism | 0.82493575 |
| 141 | MP0005220_abnormal_exocrine_pancreas | 0.82390607 |
| 142 | MP0002163_abnormal_gland_morphology | 0.80365548 |
| 143 | MP0003183_abnormal_peptide_metabolism | 0.80302692 |
| 144 | MP0002160_abnormal_reproductive_system | 0.79277078 |
| 145 | MP0000477_abnormal_intestine_morphology | 0.78985725 |
| 146 | MP0000470_abnormal_stomach_morphology | 0.78106869 |
| 147 | MP0003705_abnormal_hypodermis_morpholog | 0.77585013 |
| 148 | MP0009278_abnormal_bone_marrow | 0.76960803 |
| 149 | MP0005670_abnormal_white_adipose | 0.76622180 |
| 150 | MP0002098_abnormal_vibrissa_morphology | 0.76552490 |
| 151 | MP0005023_abnormal_wound_healing | 0.76089495 |
| 152 | MP0010386_abnormal_urinary_bladder | 0.75856445 |
| 153 | MP0002060_abnormal_skin_morphology | 0.75254975 |
| 154 | MP0003453_abnormal_keratinocyte_physiol | 0.74874516 |
| 155 | MP0000358_abnormal_cell_content/ | 0.73705740 |
| 156 | MP0008058_abnormal_DNA_repair | 0.73351460 |
| 157 | MP0000465_gastrointestinal_hemorrhage | 0.73003572 |
| 158 | MP0002019_abnormal_tumor_incidence | 0.72969273 |
| 159 | MP0005621_abnormal_cell_physiology | 0.72082648 |
| 160 | MP0002876_abnormal_thyroid_physiology | 0.71833341 |
| 161 | MP0000427_abnormal_hair_cycle | 0.71158035 |
| 162 | MP0003699_abnormal_female_reproductive | 0.68848214 |
| 163 | MP0010678_abnormal_skin_adnexa | 0.65013213 |
| 164 | MP0000371_diluted_coat_color | 0.64808374 |
| 165 | MP0004133_heterotaxia | 0.63783320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.74159377 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 3.67827502 |
| 3 | Chromsome breakage (HP:0040012) | 3.58227172 |
| 4 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.57571346 |
| 5 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.51566588 |
| 6 | Generalized aminoaciduria (HP:0002909) | 3.49541379 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.49422013 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 3.48659652 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.43617344 |
| 10 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37019514 |
| 11 | Squamous cell carcinoma (HP:0002860) | 3.30186421 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.21076289 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.17325183 |
| 14 | Poikiloderma (HP:0001029) | 3.16390138 |
| 15 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.14079585 |
| 16 | Fat malabsorption (HP:0002630) | 3.08536277 |
| 17 | Birth length less than 3rd percentile (HP:0003561) | 3.05925439 |
| 18 | Xanthomatosis (HP:0000991) | 2.99851963 |
| 19 | Clumsiness (HP:0002312) | 2.96406297 |
| 20 | Ileus (HP:0002595) | 2.91979174 |
| 21 | Hyperglycinuria (HP:0003108) | 2.91969550 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 2.87985533 |
| 23 | Hyperammonemia (HP:0001987) | 2.82319235 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 2.78321350 |
| 25 | Progressive muscle weakness (HP:0003323) | 2.75232533 |
| 26 | Petechiae (HP:0000967) | 2.70600412 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 2.68737476 |
| 28 | Homocystinuria (HP:0002156) | 2.66628376 |
| 29 | Abnormality of homocysteine metabolism (HP:0010919) | 2.66628376 |
| 30 | Pustule (HP:0200039) | 2.66616654 |
| 31 | * Prolonged partial thromboplastin time (HP:0003645) | 2.65498713 |
| 32 | Steatorrhea (HP:0002570) | 2.65422007 |
| 33 | Selective tooth agenesis (HP:0001592) | 2.62010217 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.60581584 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.60429759 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.60429759 |
| 37 | Hyperglycinemia (HP:0002154) | 2.58088228 |
| 38 | Nausea (HP:0002018) | 2.57313114 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.54742238 |
| 40 | Abnormality of the preputium (HP:0100587) | 2.54293897 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.52332193 |
| 42 | * Abnormality of the intrinsic pathway (HP:0010989) | 2.51667702 |
| 43 | Hypoplasia of the thymus (HP:0000778) | 2.51585951 |
| 44 | Hypolipoproteinemia (HP:0010981) | 2.50856983 |
| 45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.48638250 |
| 46 | Deep venous thrombosis (HP:0002625) | 2.47952952 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.47895684 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.47895684 |
| 49 | Joint hemorrhage (HP:0005261) | 2.46745512 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44080317 |
| 51 | Vaginal fistula (HP:0004320) | 2.42738842 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.42590826 |
| 53 | Meckel diverticulum (HP:0002245) | 2.41935560 |
| 54 | Intestinal fistula (HP:0100819) | 2.38596769 |
| 55 | Renal cortical cysts (HP:0000803) | 2.38136533 |
| 56 | Hypercholesterolemia (HP:0003124) | 2.38091422 |
| 57 | Abnormality of the ileum (HP:0001549) | 2.38077939 |
| 58 | Hyperbilirubinemia (HP:0002904) | 2.36279726 |
| 59 | Periodontitis (HP:0000704) | 2.33779133 |
| 60 | Microvesicular hepatic steatosis (HP:0001414) | 2.32956816 |
| 61 | * Abnormal protein glycosylation (HP:0012346) | 2.32885894 |
| 62 | * Abnormal glycosylation (HP:0012345) | 2.32885894 |
| 63 | * Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.32885894 |
| 64 | * Abnormal protein N-linked glycosylation (HP:0012347) | 2.32885894 |
| 65 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.29031616 |
| 66 | Dysmetric saccades (HP:0000641) | 2.29001144 |
| 67 | Systemic lupus erythematosus (HP:0002725) | 2.28718294 |
| 68 | Entropion (HP:0000621) | 2.27899005 |
| 69 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.27608576 |
| 70 | Absent radius (HP:0003974) | 2.25814758 |
| 71 | Recurrent abscess formation (HP:0002722) | 2.25335944 |
| 72 | Trismus (HP:0000211) | 2.24237685 |
| 73 | Rectovaginal fistula (HP:0000143) | 2.24201008 |
| 74 | Rectal fistula (HP:0100590) | 2.24201008 |
| 75 | * Type I transferrin isoform profile (HP:0003642) | 2.22578184 |
| 76 | Lip pit (HP:0100267) | 2.20976951 |
| 77 | 3-Methylglutaconic aciduria (HP:0003535) | 2.19610525 |
| 78 | Hyperlipoproteinemia (HP:0010980) | 2.19061288 |
| 79 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.18341873 |
| 80 | Abnormality of alanine metabolism (HP:0010916) | 2.18341873 |
| 81 | Hyperalaninemia (HP:0003348) | 2.18341873 |
| 82 | Recurrent fungal infections (HP:0002841) | 2.17328647 |
| 83 | Ketosis (HP:0001946) | 2.16791028 |
| 84 | Abnormality of methionine metabolism (HP:0010901) | 2.16389650 |
| 85 | Recurrent bacterial skin infections (HP:0005406) | 2.13574827 |
| 86 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11782949 |
| 87 | Protruding tongue (HP:0010808) | 2.11297716 |
| 88 | Abnormality of DNA repair (HP:0003254) | 2.08330459 |
| 89 | Sparse lateral eyebrow (HP:0005338) | 2.07074283 |
| 90 | Absent thumb (HP:0009777) | 2.06976158 |
| 91 | Combined immunodeficiency (HP:0005387) | 2.06812151 |
| 92 | Aplasia involving forearm bones (HP:0009822) | 2.05616862 |
| 93 | Absent forearm bone (HP:0003953) | 2.05616862 |
| 94 | Multiple enchondromatosis (HP:0005701) | 2.04396375 |
| 95 | Rough bone trabeculation (HP:0100670) | 2.04218949 |
| 96 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.04197718 |
| 97 | Abnormality of chromosome stability (HP:0003220) | 2.03463209 |
| 98 | Hypochromic anemia (HP:0001931) | 2.01973265 |
| 99 | Breast hypoplasia (HP:0003187) | 2.01480042 |
| 100 | Horseshoe kidney (HP:0000085) | 2.01441366 |
| 101 | Late onset (HP:0003584) | 2.01264115 |
| 102 | Amelogenesis imperfecta (HP:0000705) | 2.00745334 |
| 103 | Severe combined immunodeficiency (HP:0004430) | 2.00510293 |
| 104 | Lethargy (HP:0001254) | 2.00207993 |
| 105 | Abnormality of serum amino acid levels (HP:0003112) | 1.99185944 |
| 106 | Chronic diarrhea (HP:0002028) | 1.99102083 |
| 107 | Premature ovarian failure (HP:0008209) | 1.98259265 |
| 108 | Abnormality of T cell number (HP:0011839) | 1.97690181 |
| 109 | Ectopic kidney (HP:0000086) | 1.96820777 |
| 110 | Symptomatic seizures (HP:0011145) | 1.96489720 |
| 111 | Recurrent viral infections (HP:0004429) | 1.96439810 |
| 112 | Complement deficiency (HP:0004431) | 1.95927946 |
| 113 | Myocardial infarction (HP:0001658) | 1.95729749 |
| 114 | Congenital, generalized hypertrichosis (HP:0004540) | 1.94962872 |
| 115 | Acanthocytosis (HP:0001927) | 1.92684061 |
| 116 | Opisthotonus (HP:0002179) | 1.91007100 |
| 117 | Abnormality of purine metabolism (HP:0004352) | 1.90303305 |
| 118 | Urethral obstruction (HP:0000796) | 1.90236132 |
| 119 | Microretrognathia (HP:0000308) | 1.90200382 |
| 120 | Pancreatitis (HP:0001733) | 1.89458812 |
| 121 | Metabolic acidosis (HP:0001942) | 1.88992750 |
| 122 | Carpal bone hypoplasia (HP:0001498) | 1.88991780 |
| 123 | Abnormal cartilage morphology (HP:0002763) | 1.88763971 |
| 124 | Gingival bleeding (HP:0000225) | 1.88640275 |
| 125 | Abnormality of T cell physiology (HP:0011840) | 1.87504390 |
| 126 | T lymphocytopenia (HP:0005403) | 1.87451949 |
| 127 | Ureteral duplication (HP:0000073) | 1.87303025 |
| 128 | Granulocytopenia (HP:0001913) | 1.86908592 |
| 129 | Cheilitis (HP:0100825) | 1.86655332 |
| 130 | Abnormal number of erythroid precursors (HP:0012131) | 1.85949388 |
| 131 | Capillary hemangiomas (HP:0005306) | 1.85829903 |
| 132 | Glycosuria (HP:0003076) | 1.85267938 |
| 133 | Abnormality of urine glucose concentration (HP:0011016) | 1.85267938 |
| 134 | * Proximal tubulopathy (HP:0000114) | 1.83640331 |
| 135 | Patellar aplasia (HP:0006443) | 1.83618955 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83537155 |
| 137 | Osteolytic defects of the hand bones (HP:0009699) | 1.83038892 |
| 138 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83038892 |
| 139 | Short thumb (HP:0009778) | 1.82618824 |
| 140 | Natal tooth (HP:0000695) | 1.82101201 |
| 141 | Abnormal trabecular bone morphology (HP:0100671) | 1.81569984 |
| 142 | Anorexia (HP:0002039) | 1.81479248 |
| 143 | Vascular calcification (HP:0004934) | 1.80186854 |
| 144 | Ketoacidosis (HP:0001993) | 1.79937840 |
| 145 | Hepatic necrosis (HP:0002605) | 1.79874246 |
| 146 | Recurrent skin infections (HP:0001581) | 1.79827709 |
| 147 | Prominent nose (HP:0000448) | 1.79403188 |
| 148 | Malnutrition (HP:0004395) | 1.79189722 |
| 149 | Eosinophilia (HP:0001880) | 1.79174877 |
| 150 | Short chin (HP:0000331) | 1.78897158 |
| 151 | Abnormality of complement system (HP:0005339) | 1.78235732 |
| 152 | Abnormality of T cells (HP:0002843) | 1.77280610 |
| 153 | Hypoalphalipoproteinemia (HP:0003233) | 1.76359998 |
| 154 | Poikilocytosis (HP:0004447) | 1.76277003 |
| 155 | IgM deficiency (HP:0002850) | 1.76022270 |
| 156 | Abnormality of the nasal septum (HP:0000419) | 1.75226204 |
| 157 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75207699 |
| 158 | Protuberant abdomen (HP:0001538) | 1.74958404 |
| 159 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.74921599 |
| 160 | High pitched voice (HP:0001620) | 1.73791332 |
| 161 | Hepatocellular carcinoma (HP:0001402) | 1.71513600 |
| 162 | Abnormality of iron homeostasis (HP:0011031) | 1.70764941 |
| 163 | * IgA deficiency (HP:0002720) | 1.70684736 |
| 164 | * Thrombocytosis (HP:0001894) | 1.69288741 |
| 165 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.69034275 |
| 166 | Cutaneous melanoma (HP:0012056) | 1.68942561 |
| 167 | Cardiovascular calcification (HP:0011915) | 1.68463614 |
| 168 | Abnormal tarsal ossification (HP:0008369) | 1.65786013 |
| 169 | Persistence of primary teeth (HP:0006335) | 1.65281682 |
| 170 | Increased serum lactate (HP:0002151) | 1.64407541 |
| 171 | Abnormal pancreas size (HP:0012094) | 1.64124808 |
| 172 | Sloping forehead (HP:0000340) | 1.63429671 |
| 173 | Preauricular skin tag (HP:0000384) | 1.61486216 |
| 174 | Ependymoma (HP:0002888) | 1.61081701 |
| 175 | Clubbing of toes (HP:0100760) | 1.61069883 |
| 176 | Cellular immunodeficiency (HP:0005374) | 1.60476669 |
| 177 | Sparse eyelashes (HP:0000653) | 1.59944923 |
| 178 | Facial cleft (HP:0002006) | 1.59939226 |
| 179 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.58942556 |
| 180 | Testicular atrophy (HP:0000029) | 1.57102167 |
| 181 | Bifid tongue (HP:0010297) | 1.57022889 |
| 182 | Duplication of thumb phalanx (HP:0009942) | 1.56448480 |
| 183 | Long eyelashes (HP:0000527) | 1.54709991 |
| 184 | Septate vagina (HP:0001153) | 1.54313598 |
| 185 | Duplicated collecting system (HP:0000081) | 1.52950102 |
| 186 | Hydroxyprolinuria (HP:0003080) | 1.52854358 |
| 187 | Abnormality of proline metabolism (HP:0010907) | 1.52854358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.05150872 |
| 2 | BCKDK | 2.93851228 |
| 3 | ERN1 | 2.79651798 |
| 4 | IRAK3 | 2.68651105 |
| 5 | AKT3 | 2.44374031 |
| 6 | MAP4K1 | 2.41018442 |
| 7 | TYK2 | 2.40575242 |
| 8 | TAOK3 | 2.31998444 |
| 9 | EIF2AK1 | 2.27049473 |
| 10 | TXK | 2.26202722 |
| 11 | PIM2 | 2.23737615 |
| 12 | BUB1 | 2.03413891 |
| 13 | IRAK4 | 1.96452954 |
| 14 | EEF2K | 1.94863480 |
| 15 | ZAK | 1.92408972 |
| 16 | NME2 | 1.91604531 |
| 17 | CDC7 | 1.84135756 |
| 18 | SMG1 | 1.83822604 |
| 19 | MAP3K14 | 1.83751825 |
| 20 | TBK1 | 1.80780851 |
| 21 | FRK | 1.73005325 |
| 22 | JAK3 | 1.67459166 |
| 23 | MST4 | 1.67443815 |
| 24 | FGFR4 | 1.67049747 |
| 25 | TTK | 1.64534343 |
| 26 | IKBKE | 1.59997187 |
| 27 | MYLK | 1.54796762 |
| 28 | TESK1 | 1.52065121 |
| 29 | LATS1 | 1.48942962 |
| 30 | INSRR | 1.46912296 |
| 31 | TRIB3 | 1.43654957 |
| 32 | ZAP70 | 1.42519280 |
| 33 | EIF2AK3 | 1.42490735 |
| 34 | MET | 1.41072898 |
| 35 | SRPK1 | 1.38081042 |
| 36 | VRK2 | 1.37390871 |
| 37 | CHEK2 | 1.36629813 |
| 38 | KDR | 1.36316538 |
| 39 | JAK1 | 1.34952531 |
| 40 | PKN2 | 1.32649680 |
| 41 | NEK9 | 1.31427963 |
| 42 | MAP3K3 | 1.30017797 |
| 43 | STK10 | 1.28442188 |
| 44 | MAP2K3 | 1.28172984 |
| 45 | TLK1 | 1.28083600 |
| 46 | NUAK1 | 1.25989134 |
| 47 | TESK2 | 1.22201713 |
| 48 | IKBKB | 1.21151308 |
| 49 | MKNK2 | 1.17512585 |
| 50 | STK16 | 1.17059940 |
| 51 | PLK4 | 1.16845039 |
| 52 | MST1R | 1.10025425 |
| 53 | MTOR | 1.09815333 |
| 54 | RPS6KA4 | 1.09704556 |
| 55 | PRKCI | 1.06754339 |
| 56 | ERBB4 | 1.06364380 |
| 57 | ICK | 1.06215158 |
| 58 | TEC | 1.06072128 |
| 59 | BTK | 1.04429504 |
| 60 | FLT3 | 1.03097879 |
| 61 | PIK3CG | 1.02756302 |
| 62 | MAPKAPK3 | 1.02503314 |
| 63 | PBK | 1.01408451 |
| 64 | PIM1 | 1.00280719 |
| 65 | CHEK1 | 0.99603919 |
| 66 | EPHA2 | 0.99482758 |
| 67 | BMPR1B | 0.99071049 |
| 68 | CDK7 | 0.96792429 |
| 69 | ACVR1B | 0.95792223 |
| 70 | WNK4 | 0.95193362 |
| 71 | PLK1 | 0.95182187 |
| 72 | NLK | 0.94923708 |
| 73 | EIF2AK2 | 0.94764106 |
| 74 | LRRK2 | 0.90482081 |
| 75 | TRPM7 | 0.90055348 |
| 76 | SIK1 | 0.89437756 |
| 77 | KIT | 0.88769575 |
| 78 | MAPK11 | 0.88191849 |
| 79 | STK4 | 0.87775832 |
| 80 | PTK2 | 0.87449896 |
| 81 | ITK | 0.85686334 |
| 82 | BMX | 0.84677261 |
| 83 | ATR | 0.79716326 |
| 84 | NME1 | 0.79608983 |
| 85 | PIK3CA | 0.79149013 |
| 86 | CAMK1D | 0.78967493 |
| 87 | PASK | 0.77158563 |
| 88 | BRSK2 | 0.76673497 |
| 89 | CHUK | 0.74638216 |
| 90 | TAF1 | 0.74296218 |
| 91 | FGFR1 | 0.72930872 |
| 92 | STK38L | 0.72563836 |
| 93 | AURKB | 0.70503253 |
| 94 | STK3 | 0.70218326 |
| 95 | MAP3K9 | 0.69125363 |
| 96 | NEK2 | 0.68918573 |
| 97 | CSK | 0.68892987 |
| 98 | ATM | 0.68741829 |
| 99 | CSF1R | 0.68441680 |
| 100 | PTK6 | 0.67875367 |
| 101 | AURKA | 0.67751671 |
| 102 | CDC42BPA | 0.64705491 |
| 103 | EPHA3 | 0.64368188 |
| 104 | MARK3 | 0.62783242 |
| 105 | DMPK | 0.62361166 |
| 106 | BRSK1 | 0.62147555 |
| 107 | RPS6KB2 | 0.61757607 |
| 108 | LYN | 0.61547047 |
| 109 | VRK1 | 0.60919810 |
| 110 | SYK | 0.60346782 |
| 111 | MAP3K11 | 0.60003653 |
| 112 | PLK3 | 0.59324866 |
| 113 | PRKG2 | 0.58909185 |
| 114 | MAP2K2 | 0.56514955 |
| 115 | NEK1 | 0.55932960 |
| 116 | JAK2 | 0.55860580 |
| 117 | BRD4 | 0.53435602 |
| 118 | TGFBR2 | 0.53407966 |
| 119 | CDK8 | 0.52475202 |
| 120 | EPHB1 | 0.52261673 |
| 121 | PDK2 | 0.52260177 |
| 122 | WEE1 | 0.51692314 |
| 123 | LATS2 | 0.51583941 |
| 124 | MAP3K8 | 0.49262567 |
| 125 | MKNK1 | 0.47139444 |
| 126 | LCK | 0.45748699 |
| 127 | BLK | 0.44209207 |
| 128 | TSSK6 | 0.44170806 |
| 129 | CLK1 | 0.43941313 |
| 130 | PAK4 | 0.43396973 |
| 131 | MUSK | 0.42957287 |
| 132 | CCNB1 | 0.42321629 |
| 133 | MAPKAPK2 | 0.42112855 |
| 134 | CDK1 | 0.41783957 |
| 135 | CAMK1G | 0.41517960 |
| 136 | LMTK2 | 0.40798337 |
| 137 | RPS6KA5 | 0.40791457 |
| 138 | GRK1 | 0.40369820 |
| 139 | ABL2 | 0.39013298 |
| 140 | MELK | 0.37789728 |
| 141 | CDK9 | 0.37431975 |
| 142 | RPS6KA6 | 0.37086407 |
| 143 | TTN | 0.36855034 |
| 144 | CDK4 | 0.35963909 |
| 145 | RPS6KB1 | 0.35697947 |
| 146 | CDK2 | 0.35028276 |
| 147 | ALK | 0.34623865 |
| 148 | STK39 | 0.33669416 |
| 149 | IRAK1 | 0.33635025 |
| 150 | MAP3K10 | 0.33609882 |
| 151 | GRK6 | 0.33105238 |
| 152 | STK24 | 0.33069293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.30077532 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.26061931 |
| 3 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.23441402 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13199381 |
| 5 | RNA transport_Homo sapiens_hsa03013 | 2.10796455 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.08304246 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97107434 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.96031200 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.91824735 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89264387 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 1.77122226 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76722363 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71961449 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.71413042 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69450452 |
| 16 | Basal transcription factors_Homo sapiens_hsa03022 | 1.67541460 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.57988571 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.54238260 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.53866570 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.53008312 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.52637914 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52385597 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47406006 |
| 24 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.47210903 |
| 25 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.47167771 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44488209 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.44162544 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43863762 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42465938 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.42400649 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.39355571 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.39246137 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38801541 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.36774294 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.36289521 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34260866 |
| 37 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.33357203 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.32018767 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.29867211 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29438358 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29435600 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.29274990 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.28469374 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.27436010 |
| 45 | Cell cycle_Homo sapiens_hsa04110 | 1.26953314 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24114221 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24030285 |
| 48 | DNA replication_Homo sapiens_hsa03030 | 1.23846525 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22987137 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.21034898 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.21006253 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20659040 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18070018 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17137590 |
| 55 | RNA degradation_Homo sapiens_hsa03018 | 1.16493530 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15598286 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14782963 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14778415 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.13300788 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10828119 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09774797 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.08055591 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07592026 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05086904 |
| 65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04736297 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03773860 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 1.02355438 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.02289578 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 1.01084942 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00631759 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99898441 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.99664004 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98961526 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.98480174 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.96179470 |
| 76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95627844 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95100747 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.93854563 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93714165 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91971578 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88133642 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86508863 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.86178351 |
| 84 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.84159487 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83707025 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83552257 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.83056608 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.80455572 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.78510365 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77631249 |
| 91 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74959294 |
| 92 | Ribosome_Homo sapiens_hsa03010 | 0.73685545 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.70529208 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69856616 |
| 95 | Measles_Homo sapiens_hsa05162 | 0.66748554 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65621866 |
| 97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63522387 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63306046 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62999687 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62902966 |
| 101 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62535840 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62485625 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.62467444 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61167223 |
| 105 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60809695 |
| 106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59546367 |
| 107 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.58522788 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58122259 |
| 109 | Homologous recombination_Homo sapiens_hsa03440 | 0.58010344 |
| 110 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.57510217 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55367027 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54573164 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53738440 |
| 114 | Lysosome_Homo sapiens_hsa04142 | 0.53142951 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51241589 |
| 116 | Allograft rejection_Homo sapiens_hsa05330 | 0.50896355 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50221705 |
| 118 | Bladder cancer_Homo sapiens_hsa05219 | 0.49555631 |
| 119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49415584 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48553829 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48513508 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45128969 |
| 123 | Influenza A_Homo sapiens_hsa05164 | 0.44854461 |
| 124 | Lysine degradation_Homo sapiens_hsa00310 | 0.43955228 |
| 125 | Adherens junction_Homo sapiens_hsa04520 | 0.43721667 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42962545 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.42336064 |
| 128 | Prostate cancer_Homo sapiens_hsa05215 | 0.42085898 |
| 129 | Mismatch repair_Homo sapiens_hsa03430 | 0.41719230 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40606095 |
| 131 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.40353050 |
| 132 | Hepatitis C_Homo sapiens_hsa05160 | 0.39878421 |
| 133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38029171 |
| 134 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37369074 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.37359444 |

